Etopophos, with its active ingredient etoposide phosphate, is a potent chemotherapeutic agent used in the treatment of various types of cancer. It belongs to a class of drugs known as podophyllotoxin derivatives, which work by inhibiting the enzyme topoisomerase II, leading to DNA damage and ultimately causing cancer cell death. Etopophos is specifically used in the management of testicular cancer and small cell lung cancer, among others. It is administered intravenously and is often part of a combination chemotherapy regimen, working synergistically with other anticancer drugs to enhance treatment efficacy. Like all chemotherapy drugs, Etopophos can cause a range of side effects, which necessitates careful monitoring by healthcare professionals during treatment.